These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28979335)

  • 21. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
    Eckle T; Jahn G; Hamprecht K
    J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report.
    Green CB; O'Riordan A; Griffiths P; Haque T
    J Clin Virol; 2016 Jul; 80():24-6. PubMed ID: 27131599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistant cytomegalovirus in intestinal and multivisceral transplant recipients.
    Timpone JG; Yimen M; Cox S; Teran R; Ajluni S; Goldstein D; Fishbein T; Kumar PN; Matsumoto C
    Transpl Infect Dis; 2016 Apr; 18(2):202-9. PubMed ID: 26853894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistant Cytomegalovirus Infection in Solid-organ Transplantation: Single-center Experience, Literature Review of Risk Factors, and Proposed Preventive Strategies.
    Majeed A; Latif A; Kapoor V; Sohail A; Florita C; Georgescu A; Zangeneh T
    Transplant Proc; 2018 Dec; 50(10):3756-3762. PubMed ID: 30586840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.
    Boivin G; Goyette N; Gilbert C; Roberts N; Macey K; Paya C; Pescovitz MD; Humar A; Dominguez E; Washburn K; Blumberg E; Alexander B; Freeman R; Heaton N; Covington E
    J Infect Dis; 2004 May; 189(9):1615-8. PubMed ID: 15116297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?
    Madi N; Al-Nakib W; Pacsa A
    Adv Virol; 2011; 2011():260561. PubMed ID: 22312337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Presence of mutations associated with ganciclovir resistance in cytomegalovirus UL97 gene].
    Oyarzún MA; Bustos P; González M; Domínguez MI; Aguayo F; Nervi B; Ferres M
    Rev Med Chil; 2010 Apr; 138(4):421-7. PubMed ID: 20668789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
    Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of UL97 gene mutations and polymorphisms in cytomegalovirus infection in the colon associated with or without ulcerative colitis.
    Tamura S; Osawa S; Ishida N; Miyazu T; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Kosugi I; Furuta T; Sugimoto K
    Sci Rep; 2021 Jul; 11(1):13676. PubMed ID: 34211066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis.
    Erice A; Borrell N; Li W; Miller WJ; Balfour HH
    J Infect Dis; 1998 Aug; 178(2):531-4. PubMed ID: 9697737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in Tehran.
    Javad Hosseini SM; Nemati E; Behzadian F; Einollahi B; Rahimi Petrudy A; Sohraby M; Taghipour M; Motalebi M
    Transplant Proc; 2015 May; 47(4):1140-2. PubMed ID: 26036539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research for Cytomegalovirus Mutations Associated With Resistance to Antivirals in Kidney Transplant Receptors.
    Sant' Anna CC; Migone SRDC; Rocha CAMD; Mello Júnior FAR; Seabra AD; Pontes TB; Rodrigues JM; Soares SA; Rego VP; Figueira JP; Rodrigues APM; Burbano RMR
    Cell Transplant; 2023; 32():9636897231195245. PubMed ID: 37724822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of a UL97 gene mutation conferring ganciclovir resistance in human cytomegalovirus: prevalence of the D605E polymorphism in Korean immunocompromised patients.
    Sung H; An D; Lee SO; Choi SH; Kim SH; Chi HS; Kim MN
    Ann Clin Lab Sci; 2012; 42(4):429-34. PubMed ID: 23090742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir.
    Chou S; Waldemer RH; Senters AE; Michels KS; Kemble GW; Miner RC; Drew WL
    J Infect Dis; 2002 Jan; 185(2):162-9. PubMed ID: 11807689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
    Marfori JE; Exner MM; Marousek GI; Chou S; Drew WL
    J Clin Virol; 2007 Feb; 38(2):120-5. PubMed ID: 17157554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.
    Choi SH; Hwang JY; Park KS; Kim Y; Lee SH; Yoo KH; Kang ES; Ahn JH; Sung KW; Koo HH; Kim YJ
    Transpl Infect Dis; 2014 Dec; 16(6):919-29. PubMed ID: 25405808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus UL97 and glycoprotein B (gB) sequences in tissues from immunocompromised patients with ganciclovir-resistant virus infection.
    Li W; Anwar F; Jesurrun J; Erice A
    Scand J Infect Dis; 1999; 31(6):549-53. PubMed ID: 10680983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.